Fundz

Kyntra Bio Appoints Andrew E. Singer as Class III Director

PUBLIC · KYNBOct 01, 2026

Position

Director

Company

Kyntra Bio

Andrew E. Singer
BiotechnologyHealth Care

Description

Kyntra Bio, Inc. has appointed Andrew E. Singer, MBA, as a Class III director effective October 1, 2026

Company Information

Company

Kyntra Bio

About

Kyntra Bio, Inc. is a biotechnology company based in San Francisco, California. The company focuses on developing innovative therapies and solutions in the biotech sector. Kyntra Bio seeks to advance healthcare through its research and development initiatives. The team is committed to creating impactful products that meet patient needs.

Fundz sees it the moment Kyntra Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kevin
Senior decision-maker at this company
••••••••@••••••••

See Kevin's verified email →

Jack
Senior decision-maker at this company
••••••••@••••••••

See Jack's verified email →

Cecelia
Senior decision-maker at this company
••••••••@••••••••

See Cecelia's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Kyntra Bio's next move

Learn about Strategic plan

Kyntra Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.